Hong Kong Life Sciences and Technologies Group Limited reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2018. For the quarter, the company reported revenue of HKD 42,853,000 against HKD 5,438,000 a year ago. Loss for the period was HKD 3,308,000 against HKD 2,335,000 a year ago. Loss per basic and diluted share was 0.05 cents against 0.04 cents a year ago. For the nine months, the company reported revenue of HKD 55,889,000 against HKD 92,398,000 a year ago. Profit for the period was HKD 370,000 against loss for the period of HKD 3,877,000 a year ago. Earnings per basic and diluted share was 0.01 cents against loss per share basic and diluted of 0.05 cents a year ago.